Clinical Trial Update: A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating patient use and functionality of formoterol delivered by a novel inhalation device in asthma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Formoterol (formoterol)

Snippet

Sponsor: Novartis | Conditions: Asthma | Phase 3 | Status: COMPLETED